Lv21
190 积分 2026-04-16 加入
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
3个月前
已完结
Mirvetuximab soravtansine dosing weight considerations
3个月前
已完结
Learnings from Approved Antibody‐Drug Conjugates: Clinical Pharmacology Perspectives
3个月前
已完结
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
7个月前
已完结
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
7个月前
已完结